These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aspirin and other platelet-aggregation inhibiting drugs. Gallus AS Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861 [TBL] [Abstract][Full Text] [Related]
4. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors. Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501 [TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase mediation of hemolysate-induced contraction in rabbit basilar artery. Zubkov AY; Ogihara K; Tumu P; Patlolla A; Lewis AI; Parent AD; Zhang J J Neurosurg; 1999 Jun; 90(6):1091-7. PubMed ID: 10350257 [TBL] [Abstract][Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
7. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate. Vanderwel M; Haslam RJ J Clin Invest; 1985 Jul; 76(1):233-40. PubMed ID: 2991338 [TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
9. Cerebral vasospasm: effects of prostaglandin synthetase inhibitors in vitro. Chapleau CE; White RP; Robertson JT Neurosurgery; 1980 Feb; 6(2):155-9. PubMed ID: 6767998 [TBL] [Abstract][Full Text] [Related]
10. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. Oelz O Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707 [TBL] [Abstract][Full Text] [Related]
11. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study. Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254 [TBL] [Abstract][Full Text] [Related]
12. Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo. Groves HM; Kinlough-Rathbone RL; Cazenave JP; Dejana E; Richardson M; Mustard JF J Lab Clin Med; 1982 Apr; 99(4):548-58. PubMed ID: 7038012 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®). Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273 [TBL] [Abstract][Full Text] [Related]
14. [Antiaggregant therapy in cerebrovascular insufficiency in the aged]. Fabris F; Pernigotti L Clin Ter; 1979 Jan; 88(1):21-31. PubMed ID: 35301 [No Abstract] [Full Text] [Related]